Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.

Scientific reports - 24 Mar 2021

Veraar Cecilia, Kliman Jonathan, Benazzo Alberto, Oberndorfer Felicitas, Laggner Maria, Hacker Philipp, Raunegger Thomas, Janik Stefan, Jaksch Peter, Klepetko Walter, Ankersmit Hendrik J, Moser Bernhard

Abstract excerpt

Chronic Lung Allograft Dysfunction (CLAD), manifesting as Bronchiolitis Obliterans Syndrome (BOS) or Restrictive Allograft Syndrome (RAS), is the main reason for adverse long-term outcome after Lung Transplantation (LTX). Until now, no specific biomarkers exist to differentiate between CLAD phenotypes. Therefore, we sought to find suitable cytokines to distinguish between BOS, RAS and Azithromycin Responsive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activins
Share to Azithromycin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bronchi

Share to Cytokines

Share to Lipocalin-2

Share to Lung Transplantation

Share to Matrix Metalloproteinase 9

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 33762606
DOI: 10.1038/s41598-021-85949-1
PMCID: PMC7990920

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential novel biomarkers for chronic lung allograft dysfunction and azithromycin responsive allograft dysfunction.PMID 33762606Read ↗

Heterogeneity of chronic lung allograft dysfunction: insights from protein expression in broncho alveolar lavage.Semantic proximity Read ↗

Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.Semantic proximity Read ↗

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms.Semantic proximity Read ↗

BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.Semantic proximity Read ↗

The ABC of transplant: ALAD, BLAD, and CLAD: definition and significance.Semantic proximity Read ↗

Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.Semantic proximity Read ↗

Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients.Semantic proximity Read ↗

Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.Semantic proximity Read ↗

Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction.Semantic proximity Read ↗

Current views on chronic rejection after lung transplantation.Semantic proximity Read ↗

Chronic lung allograft dysfunction and restrictive allograft syndrome: are phenotypes robust and helpful?Semantic proximity Read ↗

Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.